Etoposide as Salvage Therapy for Cytokine Storm Due to Coronavirus Disease 2019
- PMID: 32931823
- PMCID: PMC7486855
- DOI: 10.1016/j.chest.2020.09.077
Etoposide as Salvage Therapy for Cytokine Storm Due to Coronavirus Disease 2019
Abstract
Coronavirus disease 2019 (COVID-19) has resulted in significant morbidity and mortality because of a lack of effective therapies. Therapeutic strategies under investigation target the overactive cytokine response with anti-cytokine or immunomodulators therapies. We present a unique case of severe cytokine storm resistant to multiple anti-cytokine therapies, but eventually responsive to etoposide. Thus, etoposide may have a role as salvage therapy in treatment of cytokine storm in COVID-19. To our knowledge, this is the first reported case of use of etoposide in COVID-19.
Keywords: COVID-19; etoposide.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Etoposide for Cytokine Storm Because of Coronavirus Disease 2019.Chest. 2021 Apr;159(4):1678-1679. doi: 10.1016/j.chest.2020.10.090. Epub 2021 Apr 6. Chest. 2021. PMID: 34021998 Free PMC article. No abstract available.
-
Response.Chest. 2021 Apr;159(4):1679. doi: 10.1016/j.chest.2020.11.035. Epub 2021 Apr 6. Chest. 2021. PMID: 34021999 Free PMC article. No abstract available.
References
-
- COVID-19 Map—Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
